Clearside Biomedical IPO Research Information

Clearside Biomedical IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Clearside Biomedical, and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Clearside Biomedical	CLSD - NASDAQ	$7.00-$7.00	$7.00	$8.00	7.2 million	6/2/2016
Underwriter(s): Cowen & Co., Stifel
Co-Manager(s): Needham & Co., Wedbush PacGrow
Industry: Health Care
Filing(s): Filed 2016-01-08 Terms Added 2016-05-11 Revised Terms 2016-06-01

Clearside Biomedical Quote & Chart - Click for current quote - CLSD

About Clearside Biomedical (adapted from Clearside Biomedical prospectus):
They are a late-stage clinical biopharmaceutical company developing first-in-class drug therapies to treat blinding diseases of the eye.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as "CLSD" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.